Alzheimer’s Current Studies
Currently Enrolling Studies
TRONTIER 1 Study
Help find potential treatment options for Alzheimer’s disease.
The TRONTIER 1 clinical study aims to determine if an experimental drug can help slow down Alzheimer’s disease. TRONTIER 1 will include approximately 800 adults who have a recent diagnosis of mild cognitive impairment or mild dementia due to Alzheimer’s disease.
You may be eligible if:
- You are between the ages of 50 and 90 years
- You are showing early symptoms of mild cognitive impairment or Alzheimer’s disease, or have already been diagnosed
- You are able to attend study visits with a study partner for 18 months
Other criteria will apply. Contact us today.
Merck Study
Do you or someone you know have mild cognitive impairment or mild dementia due to Alzheimer’s disease?
Learn about a clinical trial for early Alzheimer’s disease.
Who can join this clinical trial?
There are eligibility criteria that will determine if you qualify to participate. You may be able to join this clinical trial if you:
- Are 50-85 years of age
- Have mild cognitive impairment or mild dementia due to Alzheimer’s disease
- Have a person (trial partner) who can go with you to specific trial visits
Other criteria will apply.
Learn more by contacting us today.
TRAVELLER Study
A study to assess your potential eligibility for Roche Alzheimer’s disease clinical studies. See if you might be a good fit for a Roche Alzheimer’s disease clinical study where treatments are being tested.
You may be able to participate in the TRAVELLER study if you:
- Are between 50 and 90 years of age
- Have had concerns about your memory or been diagnosed with mild cognitive impairment or mild dementia due to Alzheimer’s disease within the last year
Other criteria will apply.
Learn more by contacting us today.
Closed To Enrollment
Share On: